Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/93445
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Cancer pain and opioids - past, present, and future
Author: Crawford, G.B.
Citation: Oncology & hematology review, 2015; 11(1):56-57
Publisher: Touch Digital Media
Issue Date: 2015
ISSN: 2052-3815
2052-3823
Statement of
Responsibility: 
Gregory B Crawford
Abstract: The Cancer Council Australia and Cancer Institute New South Wales are two Australian organizations that are providing useful resources to support evidence-based prescribing of opioids in cancer pain. Morphine remains the preeminent medication for nociceptive cancer pain. Our understanding of the action of opioids, and how relatively recently these developments are, assists in putting pain and suffering in the context of “total pain.” Increasing understanding of the how pain is understood is leading to new insights with an increasing emphasis on the neuroimmuno- pharmacology of pain.
Keywords: Cancer pain; morphine; opioid conversion; neuro-immuno-pharmacology
Description: Editorial
Rights: This article is published under the Creative Commons Attribution Noncommercial License, which permits any noncommercial use, distribution, adaptation, and reproduction provided the original author(s) and source are given appropriate credit.
DOI: 10.17925/OHR.2015.11.01.56
Published version: http://www.touchoncology.com/journals/oncology-hematology-review-us
Appears in Collections:Aurora harvest 2
Medicine publications

Files in This Item:
File Description SizeFormat 
hdl_93445.pdfPublished version631.5 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.